AESP
AESPCIK 0002082526
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade AESP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
AESP files S-1/A for $125M SPAC IPO at $10.00 per unit, with founder shares at 30% post-offering
6 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 18, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| Formation and operating costs | (104,406) | (164,471) |
| Other income: | ||
| Interest income on cash held in trust account | 372,790 | 372,790 |
| Total other income | 372,790 | 372,790 |
| Net Income | 268,384 | 208,319 |
| Basic and diluted weighted average shares, Class A ordinary shares subject to possible redemption | 4,244,505 | 2,133,978 |
| Basic and diluted net income per ordinary share | 0.08 | 0.15 |
| Basic and diluted weighted average shares, Class A and Class B ordinary shares not subject to possible redemption (1)(2) | 6,413,840 | 6,287,977 |
| Basic and diluted net loss per Class B ordinary share | (0.01) | (0.02) |
Condensed Balance Sheet (Unaudited)
| Description | June 30, 2026 (Unaudited) | December 31, 2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash | 302,745 | - |
| Prepaid expenses | 140,477 | - |
| Deferred offering costs | - | 299,009 |
| Total Current Assets | 443,222 | 299,009 |
| Cash held in trust account | 144,122,790 | - |
| Total Assets | 144,566,012 | 299,009 |
| LIABILITIES AND SHAREHOLDERS’DEFICIT | ||
| Current Liabilities | ||
| Accrued offering costs | 3,500 | 35,000 |
| Advance from related party | 21,654 | - |
| Promissory note related party | - | 307,760 |
| Total Current Liabilities | 25,154 | 342,760 |
| Deferred Underwriting Fee | 4,312,500 | - |
| Total Liabilities | 4,337,654 | 342,760 |
| Commitments and Contingencies (Note 6) | - | - |
| Class A ordinary shares subject to redemption, $0.0001 par value; 450,000,000 shares authorized; 14,375,000 shares issued and outstanding, at redemption price $10.03 as of June 30, 2026 | 144,122,790 | - |
| Shareholders’ Deficit | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | - | - |
| Class A ordinary shares, $0.0001 par value; 450,000,000 shares authorized; 853,125 issued and outstanding (including 590,625 restricted Class A ordinary shares, excluding 14,375,000 Class A ordinary shares subject to redemption) | 85 | - |
| Class B ordinary shares, $0.0001 par value; 45,000,000 shares authorized; 6,160,715 issued and outstanding(1)(2) | 616 | 616 |
| Additional paid-in capital | - | 24,384 |
| Accumulated Deficit | (3,870,133) | (43,751) |
| Subscription receivable | (25,000) | (25,000) |
| Total Shareholders’ Deficit | (3,894,432) | (43,751) |
| Total Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit | 144,566,012 | 299,009 |
Condensed Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net Income | 208,319 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest income on cash held in trust account | (372,790) |
| Formation and operating costs paid by Sponsor from Promissory Note a related party | 87,609 |
| Change in operating assets and liabilities | |
| Prepaid expense | (140,477) |
| Net cash used in operating activities | (217,339) |
| Cash flow from Investing Activities: | |
| Investment of cash in trust account | (143,750,000) |
| Net cash used in Investing Activities | (143,750,000) |
| Cash flow from Financing Activities: | |
| Proceeds from Initial Public Offering | 143,750,000 |
| Proceeds from sale of private placement units | 2,075,000 |
| Payment of cash underwriting fee (including payments to underwriting counsel) | (1,180,000) |
| Payment of accrued offering costs | (374,916) |
| Net cash provided by Financing Activities | 144,270,084 |
| Net Change in Cash | 302,745 |
| Cash Beginning of period | - |
| Cash End of period | 302,745 |
| Supplemental Disclosures of Noncash Investing and Financing Activities | |
| Deferred offering costs included in accrued offering costs | 343,416 |
| Deferred offering costs included in promissory note | 154,631 |
| Deferred offering costs included in advance from related party | 21,654 |
| Deferred underwriting fee | 4,312,500 |
| Remeasurement of Class A ordinary share at Initial Public Offering | 16,530,933 |
| Remeasurement to Accumulated Deficit | 3,661,852 |
| Accretion to redemption value | 372,790 |
| Promissory note in exchange for private units | 550,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗